TRINITY BIOTECH PLC-SPON ADR (TRIB) Stock Price & Overview
NASDAQ:TRIB • US8964385046
Current stock price
The current stock price of TRIB is 0.603 USD. Today TRIB is up by 0.84%. In the past month the price decreased by -17.6%. In the past year, price decreased by -77.67%.
TRIB Key Statistics
- Market Cap
- 11.282M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -2.68
- Dividend Yield
- N/A
TRIB Stock Performance
TRIB Stock Chart
TRIB Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to TRIB. When comparing the yearly performance of all stocks, TRIB is a bad performer in the overall market: 94.7% of all stocks are doing better.
TRIB Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to TRIB. TRIB has a bad profitability rating. Also its financial health evaluation is rather negative.
TRIB Earnings
TRIB Forecast & Estimates
For the next year, analysts expect an EPS growth of 65.8% and a revenue growth 10.13% for TRIB
TRIB Groups
Sector & Classification
TRIB Financial Highlights
Over the last trailing twelve months TRIB reported a non-GAAP Earnings per Share(EPS) of -2.68. The EPS increased by 41.07% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -31.91% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
TRIB Ownership
TRIB Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 17.91 | 178.754B | ||
| ISRG | INTUITIVE SURGICAL INC | 44.23 | 160.562B | ||
| SYK | STRYKER CORP | 21.92 | 126.877B | ||
| BSX | BOSTON SCIENTIFIC CORP | 17.96 | 93.218B | ||
| EW | EDWARDS LIFESCIENCES CORP | 26.9 | 47.074B | ||
| IDXX | IDEXX LABORATORIES INC | 38.42 | 45.348B | ||
| BDX | BECTON DICKINSON AND CO | 11.33 | 43.995B | ||
| RMD | RESMED INC | 18.25 | 32.645B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 13.61 | 32.062B | ||
| DXCM | DEXCOM INC | 24.47 | 23.946B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.72 | 17.783B | ||
| HOLX | HOLOGIC INC | 15.41 | 16.888B | ||
| PODD | INSULET CORP | 31.6 | 14.383B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About TRIB
Company Profile
Trinity Biotech Plc engages in the development, manufacture, and marketing of medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. The firm develops, acquires, manufactures and markets diagnostic systems, including both reagents and instrumentation, for the point-of-care and clinical laboratory segments of the diagnostic market. The products are used to detect infectious diseases and to quantify the level of Hemoglobin A1c and other chemical parameters in serum, plasma and whole blood, and the Company intends to develop a range of biosensor devices and related services, starting with a continuous glucose monitoring product. Its TrinScreen Human Immunodeficiency Virus (HIV) rapid point-of-care test is a high-quality, single-use immunoassays to aid in the diagnosis of HIV. The Uni-Gold range of rapid point-of-care test devices consist of high-quality, single-use immunoassays to aid in the diagnosis of HIV.
Company Info
IPO: 1992-10-21
TRINITY BIOTECH PLC-SPON ADR
Ida Business Park, Bray, Co Wicklow
DUBLIN WICKLOW IE
CEO: Ronan O'Caoimh
Employees: 401
Phone: 1135312955111
TRINITY BIOTECH PLC-SPON ADR / TRIB FAQ
What does TRIB do?
Trinity Biotech Plc engages in the development, manufacture, and marketing of medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. The firm develops, acquires, manufactures and markets diagnostic systems, including both reagents and instrumentation, for the point-of-care and clinical laboratory segments of the diagnostic market. The products are used to detect infectious diseases and to quantify the level of Hemoglobin A1c and other chemical parameters in serum, plasma and whole blood, and the Company intends to develop a range of biosensor devices and related services, starting with a continuous glucose monitoring product. Its TrinScreen Human Immunodeficiency Virus (HIV) rapid point-of-care test is a high-quality, single-use immunoassays to aid in the diagnosis of HIV. The Uni-Gold range of rapid point-of-care test devices consist of high-quality, single-use immunoassays to aid in the diagnosis of HIV.
Can you provide the latest stock price for TRINITY BIOTECH PLC-SPON ADR?
The current stock price of TRIB is 0.603 USD. The price increased by 0.84% in the last trading session.
Does TRIB stock pay dividends?
TRIB does not pay a dividend.
How is the ChartMill rating for TRINITY BIOTECH PLC-SPON ADR?
TRIB has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Can you provide the PE ratio for TRIB stock?
TRINITY BIOTECH PLC-SPON ADR (TRIB) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.68).
What is the market capitalization of TRIB stock?
TRINITY BIOTECH PLC-SPON ADR (TRIB) has a market capitalization of 11.28M USD. This makes TRIB a Nano Cap stock.